(KER) Kering - Overview
Stock: Fashion, Leather, Jewelry, Beauty, Eyewear
Dividends
| Dividend Yield | 2.67% |
| Yield on Cost 5y | 1.10% |
| Yield CAGR 5y | -6.94% |
| Payout Consistency | 96.6% |
| Payout Ratio | 136.0% |
| Risk 5d forecast | |
|---|---|
| Volatility | 41.8% |
| Relative Tail Risk | -7.47% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.10 |
| Alpha | 0.72 |
| Character TTM | |
|---|---|
| Beta | 0.192 |
| Beta Downside | 0.537 |
| Drawdowns 3y | |
|---|---|
| Max DD | 72.00% |
| CAGR/Max DD | -0.29 |
Description: KER Kering February 05, 2026
Kering SA (ticker KER) is a Paris-based luxury conglomerate that designs, manufactures, and distributes ready-to-wear, leather goods, shoes, watches, jewelry, eyewear, and beauty products across Asia-Pacific, Western Europe, North America, and Japan. Its portfolio includes flagship houses such as Gucci, Saint Laurent, Bottega Veneta, Balenciaga, Alexander McQueen, as well as jewelry brands like Boucheron, Pomellato, Qeelin, and the Kering Eyewear and Beauté divisions.
In FY 2023 Kering reported €19.8 billion of revenue, a 6 % year-over-year increase, driven primarily by a 12 % rebound in Gucci sales and a 9 % rise in Bottega Veneta. Operating profit reached €4.5 billion, translating to an operating margin of 22.5 %, while net income was €2.8 billion. The company’s cash conversion ratio improved to 0.92, indicating strong cash generation relative to earnings.
Key macro drivers for Kering include the recovery of high-net-worth consumer spending in China (estimated to contribute ~30 % of total luxury sales), persistent inflation pressures that could constrain discretionary demand, and the ongoing shift toward sustainable and digital-first retail experiences, which the sector is quantifying through ESG scores and online sales share (now ~28 % of total).
For a deeper, data-rich analysis of Kering’s valuation and risk profile, consider exploring the detailed metrics available on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 6.5
| Net Income: 2.81b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.08 > 0.02 and ΔFCF/TA -2.50 > 1.0 |
| NWC/Revenue: 8.09% < 20% (prev 11.59%; Δ -3.50% < -1%) |
| CFO/TA 0.17 > 3% & CFO 7.10b > Net Income 2.81b |
| Net Debt (15.65b) to EBITDA (9.63b): 1.62 < 3 |
| Current Ratio: 1.32 > 1.5 & < 3 |
| Outstanding Shares: last quarter (122.7m) vs 12m ago 0.27% < -2% |
| Gross Margin: 74.29% > 18% (prev 0.75%; Δ 7354 % > 0.5%) |
| Asset Turnover: 88.40% > 50% (prev 87.17%; Δ 1.23% > 0%) |
| Interest Coverage Ratio: 4.70 > 6 (EBITDA TTM 9.63b / Interest Expense TTM 1.18b) |
Altman Z'' 3.71
| A: 0.07 (Total Current Assets 11.33b - Total Current Liabilities 8.56b) / Total Assets 42.43b |
| B: 0.35 (Retained Earnings 14.90b / Total Assets 42.43b) |
| C: 0.14 (EBIT TTM 5.53b / Avg Total Assets 38.70b) |
| D: 1.12 (Book Value of Equity 30.03b / Total Liabilities 26.82b) |
| Altman-Z'' Score: 3.71 = AA |
Beneish M -3.17
| DSRI: 0.72 (Receivables 1.59b/1.96b, Revenue 34.21b/30.49b) |
| GMI: 1.01 (GM 74.29% / 75.21%) |
| AQI: 1.15 (AQ_t 0.46 / AQ_t-1 0.40) |
| SGI: 1.12 (Revenue 34.21b / 30.49b) |
| TATA: -0.10 (NI 2.81b - CFO 7.10b) / TA 42.43b) |
| Beneish M-Score: -3.17 (Cap -4..+1) = AA |
What is the price of KER shares?
Over the past week, the price has changed by -2.31%, over one month by -17.90%, over three months by -11.09% and over the past year by +5.13%.
Is KER a buy, sell or hold?
What are the forecasts/targets for the KER price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 300.3 | 16.4% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 229.7 | -11% |
KER Fundamental Data Overview February 03, 2026
P/E Trailing = 43.5269
P/E Forward = 31.8471
P/S = 2.0113
P/B = 2.1811
P/EG = 0.9905
Revenue TTM = 34.21b EUR
EBIT TTM = 5.53b EUR
EBITDA TTM = 9.63b EUR
Long Term Debt = 10.57b EUR (from longTermDebt, last quarter)
Short Term Debt = 4.01b EUR (from shortTermDebt, last quarter)
Debt = 19.89b EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = 15.65b EUR (from netDebt column, last quarter)
Enterprise Value = 49.46b EUR (31.70b + Debt 19.89b - CCE 2.13b)
Interest Coverage Ratio = 4.70 (Ebit TTM 5.53b / Interest Expense TTM 1.18b)
EV/FCF = 14.21x (Enterprise Value 49.46b / FCF TTM 3.48b)
FCF Yield = 7.04% (FCF TTM 3.48b / Enterprise Value 49.46b)
FCF Margin = 10.17% (FCF TTM 3.48b / Revenue TTM 34.21b)
Net Margin = 8.20% (Net Income TTM 2.81b / Revenue TTM 34.21b)
Gross Margin = 74.29% ((Revenue TTM 34.21b - Cost of Revenue TTM 8.79b) / Revenue TTM)
Gross Margin QoQ = 73.01% (prev 73.06%)
Tobins Q-Ratio = 1.17 (Enterprise Value 49.46b / Total Assets 42.43b)
Interest Expense / Debt = 1.60% (Interest Expense 319.0m / Debt 19.89b)
Taxrate = 27.56% (199.0m / 722.0m)
NOPAT = 4.01b (EBIT 5.53b * (1 - 27.56%))
Current Ratio = 1.32 (Total Current Assets 11.33b / Total Current Liabilities 8.56b)
Debt / Equity = 1.35 (Debt 19.89b / totalStockholderEquity, last quarter 14.77b)
Debt / EBITDA = 1.62 (Net Debt 15.65b / EBITDA 9.63b)
Debt / FCF = 4.50 (Net Debt 15.65b / FCF TTM 3.48b)
Total Stockholder Equity = 14.95b (last 4 quarters mean from totalStockholderEquity)
RoA = 7.25% (Net Income 2.81b / Total Assets 42.43b)
RoE = 18.77% (Net Income TTM 2.81b / Total Stockholder Equity 14.95b)
RoCE = 21.68% (EBIT 5.53b / Capital Employed (Equity 14.95b + L.T.Debt 10.57b))
RoIC = 14.22% (NOPAT 4.01b / Invested Capital 28.18b)
WACC = 4.52% (E(31.70b)/V(51.59b) * Re(6.62%) + D(19.89b)/V(51.59b) * Rd(1.60%) * (1-Tc(0.28)))
Discount Rate = 6.62% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: 100.0 | Cagr: 0.09%
[DCF Debug] Terminal Value 83.67% ; FCFF base≈3.59b ; Y1≈2.85b ; Y5≈1.90b
Fair Price DCF = 349.3 (EV 58.47b - Net Debt 15.65b = Equity 42.83b / Shares 122.6m; r=5.90% [WACC]; 5y FCF grow -24.62% → 2.90% )
EPS Correlation: -27.43 | EPS CAGR: -69.17% | SUE: 0.0 | # QB: 0
Revenue Correlation: 8.52 | Revenue CAGR: -0.78% | SUE: N/A | # QB: 0
EPS next Year (2026-12-31): EPS=8.22 | Chg30d=-0.132 | Revisions Net=-2 | Growth EPS=+45.6% | Growth Revenue=+2.4%